-
The Food and Drug Administration approved a new sunscreen ingredient in the U.S. for the first time in 20 years. It's been used for decades in Europe and Asia.
-
Some of the 18 cruise ship passengers in quarantine after a deadly hantavirus outbreak have had a tough time in isolation.
-
Through an innovative program, parents in Senegal had easy access to a therapeutic food that's a boon for malnourished kids. Now there are shortages. Health specialists say U.S. aid cuts are to blame.
-
They gave smartphones to 10 women from a working-class Indian community to make a documentary about their unseen and unheralded lives. The results are .... pretty cool.
-
Human bodies have a natural cooling system, but it can do only so much in high temperatures and humidity. Here's the science behind how heat kills. And how to protect yourself.
-
A newly published series of reports calls attention to a dire situation facing millions of women after childbirth — and the solutions that can prevent death from postpartum hemorrhage.
-
It’s a condition that affects about 27 million women each year.
-
Daraxonrasib is an experimental pill that doubled survival time compared to standard chemotherapy, according to the results of a clinical trial.
-
Spending too much time and money on skin care? Find out what really works to improve skin health and appearance with our one-week newsletter guide. Sign up here.
-
Trump's Department of Justice is seeking patient files that include the names of young people who have been treated in transgender clinics, as well as hospital staff who have provided care.
-
The DRC has improved testing capacity for Ebola with two facilities operating in or near the epicenter. But this still may not be enough to keep up with a rapidly expanding disease.
-
A study of more than 2,300 9- to 10-year-olds found that socioeconomic factors explained most differences in the preteens' brain development.